Highest EBITDA Growth in the Life Sciences Tools & Services Industry Detected in Shares of Albany Molecular Research (AMRI, AFFX, BRKR, PRXL, PKI)
Below are the three companies in the Life Sciences Tools & Services industry with the highest EBITDA Growth (next year estimate vs. LTM). EBITDA Growth can be valuable in predicting future cash flow generation and earnings power.
Albany Molecular Research ranks highest with a EBITDA growth of 174.8%. Following is Affymetrix with a EBITDA growth of 66.7%. Bruker ranks third highest with a EBITDA growth of 53.8%.
Parexel International follows with a EBITDA growth of 47.0%, and PerkinElmer rounds out the top five with a EBITDA growth of 38.6%.
SmarTrend recommended that subscribers consider buying shares of PerkinElmer on March 2nd, 2016 as our technology indicated a new Uptrend was in progress when shares hit $48.58. Since that recommendation, shares of PerkinElmer have risen 10.5%. We continue to monitor PerkinElmer for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.
Keywords: highest ebitda growth albany molecular research Affymetrix bruker parexel international perkinelmer